Navigation Links
Sonic Innovations Announces Results for Fourth Quarter and Full Year 2007
Date:2/5/2008

" as defined under securities laws. Actual results may differ materially and adversely from those described herein depending on a number of factors including, but not limited to, the following risks: we face aggressive competition in our business; acquisitions could be difficult to integrate and disrupt our current business and therefore may harm our operating results; we may poorly operate newly acquired businesses; we may lose a large customer or suffer a reduction in orders from a large customer; we must have innovative, technologically superior products to compete effectively; our products, due to their complexity, may contain errors or defects that are only discovered after sales by our customers, thus harming our reputation and business; we may have issues with intellectual property; and we have important international operations, particularly in Germany and Australia, which expose us to a variety of risks including government reimbursement, that could impact sales and operating results. For additional information regarding the risks inherent in our business, please see "Factors That May Affect Future Performance" included in our Annual Report on Form 10-K for the year ended December 31, 2006, as filed with the Securities and Exchange Commission.

This release contains a non-GAAP financial measure ("EBITDA"). We believe the inclusion of such a non-GAAP financial measure improves the transparency of our disclosure. We have provided a reconciliation of this non-GAAP financial measure to the most directly comparable GAAP measure.

We undertake no obligation to revise our forward-looking statements to reflect events or circumstances after the date hereof as a result of new information, future events or otherwise.

The Company will host a teleconference call in connection with this release on Tuesday, February 5, 2008 at 3:00 p.m. Mountain Time (5:00 p.m. Eastern Time).

To participate in the conference call, please call toll free (800) 291-
'/>"/>

SOURCE Sonic Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Sonic Foundry to Host Wisconsin Lt. Governor Lawton in Raising Awareness for National Depression Screening Day
2. Access Innovations Provides Support Services for Agis Network
3. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
4. Prize for Cutting-Edge Laser Innovations
5. Health Literacy Innovations Releases New Survey on Medicaid Health Literacy Standards
6. Cleveland Clinic Unveils Top 10 Medical Innovations For 2008
7. Inverness Medical Innovations Acquires Bio-Stat Healthcare Group
8. Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy
9. Young Innovations, Inc. Provides Third Quarter Conference Call Details
10. Fenwal Signs Development, Distribution and Licensing Agreement With Data Innovations, Inc.
11. Young Innovations, Inc. Announces Results for the Third Quarter Ended September 30, 2007 and Declares Quarterly Dividend

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...wswire-USNewswire/--WhenmostpeopleheartheacronymTM...ivepatientsthehelptheyneed.TMJstandsfortheTemporal...acts/connectswithyourskull(temporalbone). ,, Th...painwithchewing,clickingorpoppingofthejaw.Butmanyo...:headaches,fatigue,sleepdisturbances,irritability,...
(Date:11/25/2009)...5/PRNewswire-FirstCall/-- OnyxPharmaceuticals,Inc...sttwoinvestoreventsinDecember: ,, ASHBriefing... ,, Principalinvestigatorswilldiscussdatapresen...ctorymultiplemyeloma,asfeaturedatthe51stAmericanSo...NewOrleans,LA.Theteleconferencewillbeginat9:00a.m....
(Date:11/25/2009)...re/-SentinelleMedicalInc.,aleadingmanufacturerofbr...esasuiteofnewleadingedgeclinicalapplicationsonitsA...RadiologicalSocietyofNorthAmerica(RSNA)annualmeeti...applicationsleveragetheuniquehighqualityimagesgene...pportmultipleimagingmodalitiesformulti-parametrica...
(Date:11/25/2009).../PRNewswire-USNewswire/--AnarticlebyJanetWoodcock,...esearch,titled"ADifficultBalance-PainManagement,Dr...TheNewEnglandJournalofMedicine. ,, (Logo: http:...,, Inthearticle,WoodcockdiscussesFDAeffortstost...honeeditandmanagingtherisksposedbyvariousanalgesic...
(Date:11/25/2009)...ewswire/--TheBayAreaAirQualityManagementDistrictis...Air Alert forThursday,November26,2009whichban...el,bothindoorsandoutdoors. ,, "Cold,stillweathe...JackBroadbent,executiveofficeroftheAirDistrict."We...neighborsandfellowcommunitymembersthisThanksgiving...
Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2
...ore research is being published showing the benefi...l tolerated by most patients due to the aftertaste...hers at Banner now say they have developed a chewa...oft chewable shell that can be taken without water...
... medications available , one must also be wary of ...ng to the Drug Control Department, 63 batches of s...killers and cardiac medicines, are being sold in B... drug racket first came to light in May-end this y...
...n B9 has been known to help in the brain developme...e to this reason it is administered to pregnant wo...ngen University, Netherlands has proposed that thi... increased levels of homocysteine. This amino acid...
... Lancet investigated the efficacy of acupuncture c...puncture in patients with osteoarthritis of the kn...reat many types of patients with chronic pain. ...o the acupuncture group, second group with 76 pati...
...able to stop the geriatric population from falling...ntain their balance. The device is called Yak...e that conforms to the footwear and helps the peop...of the number of falls they have on wearing the de...
...rom peripheral arterial disease may lose their lim...s to attend to them. Research findings report that...r surgeons, report less number of cases where pati...ften the only symptom experienced is a recurring p...
Other Medicine News:
(Date:11/25/2009)...ire-FirstCall/--Formanyofthemillionsofhearingimpai...ated hearingloss ,theholidaysmaynotbeallthathappy,...cepresidentofHearUSA(Amex: EAR ),oneofAmerica,slar...eshavelinkedhearinglosstostress,frustration,andsoc...gatheringswithfamiliesandfriends,whenmanyofthosewi...
(Date:11/25/2009)...tlinker.comannouncesthatanewmarketresearchreportis...DevicesMarketAnalysisandForecaststo2015 ,, ht...ental-Devices-Market-Analysis-and-Forecasts-to-201...sisandForecaststo2015 ,, Summary ,, Thisre...tarelatingtotheUSdentaldevicesmarket.Italsooffersd...
(Date:11/25/2009)...all/--NuVasive,Inc.(Nasdaq: NUVA ),amedicaldevicec...ptivesurgicaltreatmentsforthespine,announcedtodayt...09,at5:30p.m.ET/2:30p.m.PT.Theconferencecallwillfo...pany,sproductsandwillincludecommentsfrommanagement...nnumbersare1-877-407-4018fordomesticcallersand1-20...
Breaking Medicine Technology:For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3A Mediterranean Approach to Flavorful Living 56023 1A Mediterranean Approach to Flavorful Living 56023 2A Mediterranean Approach to Flavorful Living 56023 3Pfizer Pays a Record Amount to Settle Federal and State Fraud Investigations Into Illegal Off Label Marketing Practices 56020 1Pfizer Pays a Record Amount to Settle Federal and State Fraud Investigations Into Illegal Off Label Marketing Practices 56020 2Pfizer Pays a Record Amount to Settle Federal and State Fraud Investigations Into Illegal Off Label Marketing Practices 56020 3Pfizer Pays a Record Amount to Settle Federal and State Fraud Investigations Into Illegal Off Label Marketing Practices 56020 4eDiets com Selects Karlin+Pimsler to Lead Creative Turnaround 56017 1eDiets com Selects Karlin+Pimsler to Lead Creative Turnaround 56017 2
...groups show dose-dependent PSA d... call to be held today at 8:30 A.M. Eastern time -...: MDVN ) today announced that its selective andro...ed serum levels of prostate specific,antigen (PSA)...rolled in,the first two dose groups of its ongoing...
...ustained virologic response in non-respond...results in line with previous studies of long-acti...th less frequent dosing -, - Final data from Phas..., Annual Meeting of the American Association for t... (AASLD) -, ROCKVILLE, Ma., Nov. 5 Human G...
Other Medicine Technology:Medivation's MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial 2Medivation's MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial 3Medivation's MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial 4Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 2Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 3Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 4Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 5Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 6
Hi-Top Post Op Shoe
EZY Close
Forefoot Reliever
Ultra 90 Fixed Plantar Fasciitis Splint
Medicine Products: